IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

Informations projet

IMPORTANT

N° de convention de subvention: 101104589

DOI

10.3030/101104589

Date de signature de la CE 24 Avril 2023

Date de début 1 Mai 2023

Date de fin 30 Avril 2028

Financé au titre de

• Health

Coût total

€ 5 415 012,50

Contribution de l’UE

€ 5 415 012,50

Coordonné par

OREBRO LANS LANDSTING
Sweden

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (7)

D6.1 Dissemination, exploitation, standardization and sustainability plan

This deliverable will report plan for IMPORTANTs exploitation, dissemination and communication activities.

D2.2 IMPORTANT's technical requirements and specifications

This deliverable reports the technical requirements and specifications

D6.6 First conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster

A report with concluding remarks from the meetings within the Diagnosis and treatment cluster. The deliverable will be prepared within one month after the meeting

D6.7 First policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting

A policy brief formulating recommendations based on the research and innovation strand of the Diagnosis and treatment annual cluster meeting. The deliverable will be prepared within one month after the meeting.

D2.3 - IMPORTANT trial: Regulatory background, policy-related aspects, and standard-of-care

This report will describe the regulatory and policy aspects related to the design and execution of IMPORTANT trial and will present the current standard-of-care.

D2.1 Breast cancer challenges and clinical study requirements

This report will include the definition of the clinical requirements for the IMPORTANT study, also covering patients' aspects

D6.5 Initial common work plan for scientific collaboration under the ‘Diagnosis and treatment’ cluster.

The project will contribute to the annual cluster meeting addressing common scientific challenges, organised in close collaboration with the European Commission. Relevant national ministries, agencies and policymakers, as well as other related EU-funded projects, will be invited to these annual meetings.

Websites, patent fillings, videos etc. (2)

D6.4 IMPORTANT project website

A public website for the project.

D6.18 Common cluster brochure/video

A common cluster brochure and/or video.

Publications

Peer reviewed articles (3)

Clinical trials in older patients with cancer – typical challenges, possible solutions, and a paradigm of study design in breast cancer.

Auteurs: Karihtala, P., Schiza, A., Fountzilas, E., Geisler, J., Meattini, I., Risi, E., Biganzoli, L., & Valchis, A.
Publié dans: Acta Oncologica, Numéro 63(1), 2024, ISSN 1651-226X
Éditeur: Medical Journals Sweden AB
DOI: 10.2340/1651-226X.2023.40365

A Swarm-Based Clinical Validation Framework of Artificial Intelligence Solutions for Non-Communicable Diseases

Auteurs: Kitty Kioskli, Spyridon Papastergiou, Theofanis Fotis
Publié dans: Journal of Engineering Research and Sciences, 2023, ISSN 2831-4085
Éditeur: Journal of Engineering Research and Sciences (Standalone)
DOI: 10.55708/js0209001

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients

Auteurs: Antonis Valachis, Laura Biganzoli, Athina Christopoulou, Kamilla Fjermeros, Elena Fountzila, Jürgen Geisler, Raquel Gomez-Bravo, Peeter Karihtala, Paris Kosmidis, Angelos Koutras, Helena Linardou, Henrik Lindman, Iván Martínez-Ballestero, Anna Belén Rodríguez, Icro Meattini, Montserrat Munoz-Mateu, Mukhrizah Othman, Amanda Psyrri, Emanuela Risi, Aglaia Schiza, Nikolaos Spathas, Meri Utriainen, Luca Visani, Soledad Ballesteros, Ioannis Basdekis, Susanne Dieroff Hay, Theo Fotis, Samuel Fricker, Gimon de Graaf, Marit Jenset, Tim Kanters, Kostas Lampropoulos, Christiana Markou, Kalliopi Mastoraki, Christina Nanou, José Manuel Reales Aviles, Marianne Santaholma, Thanos Kosmidis
Publié dans: Future Oncology, 2024, ISSN 1479-6694
Éditeur: Informa UK Limited
DOI: 10.1080/14796694.2024.2413841